Weeks after a California jury hit Johnson & Johnson with a $29 million mesothelioma verdict, the company scored a win close to home. A jury in Middlesex County, New Jersey, cleared the drugmaker in a lawsuit brought by plaintiff Ricardo Rimondi alleging
read moreA filing for ozanimod was initially rejected by the US regulator in February 2017. More: Celgene resubmits MS drug, ozanimod, to FDA Source: News
read moreAimmune to file peanut allergy drug in Europe based on Phase III data showing an improvement in peanut tolerance. More: Phase III results move Aimmune’s peanut allergy drug closer to EU market Source: News
read moreCancer Research UK, LifeArc and Ono Pharmaceutical have formed a multi-million-pound drug discovery alliance. More: Cancer immunotherapy alliance formed by CR UK, Lifearc and Ono Pharma Form Source: News
read moreThe FDA has approved Novartis’ multiple sclerosis drug, Mayzent. More: Novartis' MS drug gets FDA approval Source: News
read moreMSD’s SGLT-2 inhibitor Steglatro will be available for some patients with type II diabetes on the NHS in England and Wales. More: NICE recommendation for Steglatro in type II diabetes Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals